Standout Papers
Immediate Impact
2 by Nobel laureates 38 from Science/Nature 66 standout
Citing Papers
Cushing Syndrome
2023 Standout
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
Works of Xavier Bertagna being referenced
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
2020
LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xavier Bertagna | 8468 | 7517 | 3968 | 254 | 14.2k | |
| Felix Beuschlein | 8745 | 7535 | 2860 | 416 | 13.1k | |
| Jérôme Bertherat | 9513 | 10256 | 6830 | 410 | 17.2k | |
| Martin Faßnacht | 9414 | 10781 | 7481 | 401 | 16.0k | |
| Márta Korbonits | 6785 | 3565 | 1501 | 358 | 15.0k | |
| Karel Pacák | 6771 | 7926 | 5020 | 203 | 11.0k | |
| Massimo Mannelli | 5609 | 6213 | 3868 | 214 | 8.7k | |
| Massimo Terzolo | 8249 | 8705 | 4806 | 249 | 11.6k | |
| Xavier Jeunemaı̂tre | 9047 | 5075 | 2776 | 333 | 19.4k | |
| Philippe Chanson | 11489 | 5154 | 608 | 380 | 16.1k | |
| John Newell‐Price | 10124 | 5367 | 769 | 159 | 12.0k |
All Works
Loading papers...